Det er blevet antaget, at der er en forbindelse mellem visceral lipomatose og proteasehæmmere samt lipoatrofi og nucleosid revers transkriptase inhibitorer.
A connection between visceral lipomatosis and protease inhibitors and lipoatrophy and nucleoside reverse transcriptase inhibitors has been hypothesised.